PASSAGE BIO, INC. Common Stock, Value, Issued
PASSAGE BIO, INC. (PASG) had Common Stock, Value, Issued of $6.00 thousand as of 2025-03-31, per its 10-Q filed 2025-05-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2025-05-13
- 2025-03-31: Common Stock, Value, Issued $6.00K.
- 2024-12-31: Common Stock, Value, Issued $6.00K.
- 2024-09-30: Common Stock, Value, Issued $6.00K.
- 2024-06-30: Common Stock, Value, Issued $6.00K.
| Period end | Common Stock, Value, Issued |
|---|---|
| 2025-03-31 | $6.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $6.00K 10-Q · filed 2025-05-13 |
| 2024-09-30 | $6.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $6.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $6.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $5.00K 10-K · filed 2025-03-04 |
| 2023-09-30 | $5.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $5.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $5.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $5.00K 10-K · filed 2024-03-04 |
| 2022-09-30 | $5.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $5.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $5.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $5.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | $5.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $5.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $5.00K 10-Q · filed 2021-05-05 |
| 2020-12-31 | $4.00K 10-K · filed 2022-03-03 |
| 2020-09-30 | $4.00K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $4.00K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $4.00K 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |